Why This Fund Trimmed $4 Million of Turning Point Brands Despite Surging Oral Nicotine Sales

Crown Advisors sold 35,000 TPB shares in the first quarter, with the transaction estimated at $3.90 million based on quarterly average pricing. The report is a straightforward ownership-flow update with no additional operational or earnings information. Market impact is likely limited, though the sale may be noted by investors tracking insider and institutional positioning.

Analysis

Crown Advisors sold 35,000 TPB shares in the first quarter, with the transaction estimated at $3.90 million based on quarterly average pricing. The report is a straightforward ownership-flow update with no additional operational or earnings information. Market impact is likely limited, though the sale may be noted by investors tracking insider and institutional positioning.